2007Tianjin Journal of Traditional Chinese MedicineRequires access

Experimental research on inhibitory effect of Yinlan Yigan Granules on reproduction of of HBV in vitro

Xiumei Li

Open publisher page 0 citations

Abstract

[Objective] To explore the inhibitory effect of the serum containing pharmacodynamic ingredient of Yinlan Yigan Granule (strengthening the liver) on the secretion of HBsAg and HBeAg from the cell line of human liver carcinoma(HepG2.2.15) transinfected with gene of HBV. [Methods] The tissue culture and ELISA assay were used in the experiment. [Results] On the eighth day after treated with medicine-containing serum, the TC50 on HepG2.2.15 was 11.48%, the maximum nontoxic concentration of medicine-containing serum was 6.0%. The inhibitory rate of medicine-containing serum at concentration of 6.0%, 3.0% 1.5% and 0.75% in 2.2.15 cells on the 8th day was 7.89%, 5.8%, 1.6%, 1.6% respectively on HbsAg. All the suppression ratio on HBeAg was negative. [Conclusions] Yinlan Yigan Granules has light inhibitory effect on HBsAg-secreting Hep2.2.15 and no inhibitory effect on HbeAg is noted.

About this research paper

What this paper is about

[Objective] To explore the inhibitory effect of the serum containing pharmacodynamic ingredient of Yinlan Yigan Granule (strengthening the liver) on the secretion of HBsAg and HBeAg from the cell line of human liver carcinoma(HepG2.2.15) transinfected with gene of HBV. [Methods] The tissue culture and ELISA assay were used in the experiment. [Results] On the eighth day after treated with medicine-containing serum, the TC50 on HepG2.2.15 was 11.48%, the maximum nontoxic concentration of medicine-containing serum was 6.0%. The inhibitory rate of medicine-containing serum at concentration of 6.0%, 3.0% 1.5% and 0.75% in 2.2.15 cells on the 8th day was 7.89%, 5.8%, 1.6%, 1.6% respectively on HbsAg. All the suppression ratio on HBeAg was negative. [Conclusions] Yinlan Yigan Granules has light inhibitory effect on HBsAg-secreting Hep2.2.15 and no inhibitory effect on HbeAg is noted.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

[Objective] To explore the inhibitory effect of the serum containing pharmacodynamic ingredient of Yinlan Yigan Granule (strengthening the liver) on the secretion of HBsAg and HBeAg from the cell line of human liver carcinoma(HepG2.2.15) transinfected with gene of HBV. [Methods] The tissue culture and ELISA assay were used in the experiment. [Results] On the eighth day after treated with medicine-containing serum, the TC50 on HepG2.2.15 was 11.48%, the maximum nontoxic concentration of medicine-containing serum was 6.0%. The inhibitory rate of medicine-containing serum at concentration of 6.0%, 3.0% 1.5% and 0.75% in 2.2.15 cells on the 8th day was 7.89%, 5.8%, 1.6%, 1.6% respectively on HbsAg. All the suppression ratio on HBeAg was negative. [Conclusions] Yinlan Yigan Granules has light inhibitory effect on HBsAg-secreting Hep2.2.15 and no inhibitory effect on HbeAg is noted.

Key concepts: HBsAg, HBeAg, Inhibitory postsynaptic potential, Pharmacology, In vitro, IC50, Granule (geology), Pharmacodynamics

Related papers

Back to paper searchBrowse research topicsOriginal source
Experimental research on inhibitory effect of Yinlan Yigan Granules on reproduction of of HBV in vitro — Research Paper | ScholarLens